Henderson Jane
SEC insider (Form 3/4/5 filer). CIK 0001422304. Director at Lycia Therapeutics, Inc. (LYCA) and 3 other issuers. 32 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Henderson Jane has filed insider reports for
- Lycia Therapeutics, Inc. (LYCA): Director
- Apogee Therapeutics, Inc. (APGE): Officer, Chief Financial Officer
- Akero Therapeutics, Inc. (AKRO): Director
- CARGO Therapeutics, Inc. (CRGX): Director
Henderson Jane
CIK: 0001422304
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Sep 3, 2026APGE
Apogee Therapeutics, Inc.
DispositionDirect158.4K shares- - Jul 24, 2026APGE
Apogee Therapeutics, Inc.
GiftDirect15K shares- - May 1, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect289 shares at avg. $83.16$24K - May 1, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect811 shares at avg. $81.02$66K - May 1, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect900 shares at avg. $82.60$74K - Apr 16, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect2K shares at avg. $90.00$180K - Apr 1, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect900 shares at avg. $84.46$76K - Apr 1, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect1.1K shares at avg. $85.46$94K - Mar 25, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect2K shares at avg. $85.00$170K - Mar 2, 2026APGE
Apogee Therapeutics, Inc.
SaleDirect300 shares at avg. $68.27$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 |  APGE Apogee Therapeutics, Inc. | Disposition | 158,371 | - | $0 | Direct |
| Jul 24, 2026 | APGE Apogee Therapeutics, Inc. | Gift | 15,000 | - | $0 | Direct |
| May 1, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 289 | $83.16 | $24,033 | Direct |
| May 1, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 811 | $81.02 | $65,707 | Direct |
| May 1, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 900 | $82.60 | $74,340 | Direct |
| Apr 16, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 2,000 | $90.00 | $180,000 | Direct |
| Apr 1, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 900 | $84.46 | $76,014 | Direct |
| Apr 1, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 1,100 | $85.46 | $94,006 | Direct |
| Mar 25, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 2,000 | $85.00 | $170,000 | Direct |
| Mar 2, 2026 | APGE Apogee Therapeutics, Inc. | Sale | 300 | $68.27 | $20,481 | Direct |
1-10 of 32 transactions